All Stories

  1. Racial Differences in Aggressive Uterine Cancer Linked to Genes and Immune Response

    Article • Proceedings of the National Academy of Sciences, August 2024, Proceedings of the National Academy of Sciences

    Julie Kim

  2. Comparative analysis of AKT and the related biomarkers in uterine leiomyomas with MED12, HMGA2 , and FH mutations

    Article • Genes Chromosomes and Cancer, August 2018, Wiley

    Dr Jian-Jun Wei, Julie Kim

  3. Establishment of breast tumor spheroids: An emerging research tool

    Article • Molecular Reproduction and Development, January 2018, Wiley

    Julie Kim

  4. Paracrine Pathways in Uterine Leiomyoma Stem Cells Involve Insulinlike Growth Factor 2 and Insulin Receptor A

    Article • The Journal of Clinical Endocrinology & Metabolism, January 2017, Endocrine Society

    Dr Jian-Jun Wei, Molly Moravek, Serdar Bulun, Julie Kim

  5. Synuclein-γ in uterine serous carcinoma impacts survival: An NRG Oncology/Gynecologic Oncology Group study

    Article • Cancer, December 2016, Wiley

    Dr Jian-Jun Wei, Julie Kim

  6. Novel Three Dimensional Human Endocervix Cultures Respond to 28-Day Hormone Treatment

    Article • Endocrinology, April 2015, Endocrine Society

    Julie Kim

  7. Increased AKT or MEK1/2 Activity Influences Progesterone Receptor Levels and Localization in Endometriosis

    Article • The Journal of Clinical Endocrinology & Metabolism, December 2013, Endocrine Society

    Julie Kim

  8. MK-2206, an AKT Inhibitor, Promotes Caspase-Independent Cell Death and Inhibits Leiomyoma Growth

    Article • Endocrinology, November 2013, Endocrine Society

    Julie Kim

  9. Increased Activation of the PI3K/AKT Pathway Compromises Decidualization of Stromal Cells from Endometriosis

    Article • The Journal of Clinical Endocrinology & Metabolism, January 2012, Endocrine Society

    Julie Kim